T Cell Immunotherapy for Advanced Ovarian Cancer

Condition:   Platinum Resistant Ovarian Cancer Interventions:   Procedure: Leukapheresis;   Drug: Utomilumab;   Drug: Cyclophosphamide;   Biological: T Cell Infusion;   Drug: Interleukin-2 Sponsors:   M.D. Anderson Cancer Center;   Immatics US, Inc.;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials